GADD45A promoter methylation and poor prognosis in AML: mechanism and clinical significance

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • D'Andrea, Richard (Chief Investigator (CI))
  • Lewis, Ian D. (Chief Investigator (CI))
  • To, Luen (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1231/12/14

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD206,175.00